-
Russia a terrorist state threatening world peace!
-
Veteran Lawes eyes England return after signing for Sale
-
Nepal vows action against trekker rescue scam
-
Oil prices rally, stocks edge up after Trump's latest Iran threat
-
'Charlie's Angels' stars reunite for show's 50th anniversary
-
Laughter, tears: historic day for astronaut Jenni Gibbons in Houston
-
Former Wallaby 'Iceman' Foley to retire
-
Croatia finally landmine-free 30 years after war, but wounds remain
-
Taiwan opposition leader in China: what you need to know
-
'Morale boost': NASA carries out Moon mission during tough year for science
-
UN Security Council vote expected on Hormuz resolution
-
Departing Griezmann back at Barca in search of Atletico grand finale
-
PSG look to pile misery on Liverpool as sides meet again in Champions League
-
Magic upset Pistons, Spurs suffer Wembanyama scare
-
After milestone-rich lunar flyby, astronauts start trip home
-
Cambodian deported by US faced 'misery' in Eswatini prison
-
Australian soldier arrested for alleged war crimes in Afghanistan
-
Oil prices rally, stocks mixed after Trump's latest Iran threat
-
Chalmers urges McEvoy to swim in Australia 4x100m relay team at Olympics
-
Taiwan opposition leader makes rare visit to China
-
Olympic cyclist Rohan Dennis breaks silence after wife's death
-
US Vice President Vance departs for Hungary in support of Orban
-
Ex-top aide of Spanish PM set to go on trial for graft
-
Tokyo confirms Japanese national held by Iran freed
-
AI-generated artists break through in country music
-
Rio de Janeiro's gangs hijack buses to sow chaos in war with police
-
Iran defiant as deadline looms for Trump threat to infrastructure
-
Kholo Capital and Tensai Provide R275 Million to Support Management Buy-Out ("MBO") of Isambane Mining
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - April 07
-
Formation Metals to Host Live Investor Webinar on the N2 Gold Project to Discuss Phase 1 Drill Results, including 1.75 g/t Au over 30.4 Metres, and Maiden Resource Estimate Following Fully Funded 30,000-Metre Program
-
BioNxt Secures Unitary European Patent for Sublingual Cladribine ODF Platform Across 18 Countries
-
Apex Drills 81.6 m of 2.02% REO, including 50.9 m of 2.40% REO, Extending Strike Length of Main Body, with Highly Enriched NdPr Zone at Rift
-
Evotec Nominates Dieter Weinand as Supervisory Board Chairman
-
Caledonia Mining Corporation Plc: Encouraging Results From Deep Level Drilling at Blanket Mine
-
Salam Selects GreySkies AIOps platform to Power AI-Driven Unified Service Assurance Management Center
-
Tiger's treatment battle in thoughts of stars at Masters
-
Thai amateur 'Fifa' ready for Masters kick-off
-
'Hacks' has 'perfect' ending after 5 seasons, says star Smart
-
Age and near misses don't worry Rose in Masters quest
-
'Incredibly dangerous': rescuing downed fighter crew in Iran
-
Wall Street stocks rise on hopes for US-Iran ceasefire
-
High-flying Villarreal stumble at Girona
-
Promoter defends plan for Kanye West to headline London fest
-
Napoli's Serie A title defence boosted by beating AC Milan
-
Trump lashes out at 'paper tiger' NATO while re-upping Greenland claim
-
Reed finds DP World Tour success after leaving LIV
-
Lunar crater named after Artemis commander's deceased wife
-
WNBA star Reese joining Atlanta from Chicago: club
-
Gotterup seeks rare win in Masters debut
-
Bayern's Kompany waiting on Kane for 'toughest' game at Real Madrid
Monsanto: object of Bayer desire despite GMO fears
German pharmaceutical giant Bayer sees in agroindustry giant Monsanto a gem worth at least $62 million for its dominant global position selling seeds sought by farmers of corn, soybeans, cotton and other commodity crops.
But for the Green movement, especially in Europe, Monsanto turns stomachs for unstinting promotion of genetically modified crops and its widely used herbicide Roundup, often feared as a possible carcinogen.
The merger is still under discussion -- Monsanto rejected the price as too low on Tuesday, but said it is willing to keep talking.
But it raises questions across an industry that is pushing the frontiers of biochemistry amid great nervousness, and consolidating into just a handful of very powerful firms.
- What is Monsanto? -
St. Louis, Missouri-based Monsanto was established by pharmacist John Queeny in 1901 to produce saccharine. Queeny named the company after his wife Olga Monsanto Queeny.
By the 1940s, the company was producing farm-oriented chemicals, particularly the widely used herbicide 2,4-D, and slowly became a US household name.
Combined with another dangerous chemical, 2,4-D was used to make the notorious Vietnam War-era defoliant Agent Orange.
In 1976, it launched probably its most famous product, Roundup, the world's most widely used herbicide. Its active chemical is glyphosate.
The company began in the 1970s looking at the crops that the herbicides were protected, building cell and molecular biology units. In 1982, its scientists were the first to genetically modify a plant cell.
Monsanto then started buying other seed companies and withing five years began field trials of genetically modified seeds.
It eventually developed soybean, corn, cotton, canola and other crops that were genetically engineered to be tolerant of Roundup.
In 1994, Monsanto also became the first to begin selling the biotechnology-based hormone for dairy cows, rBST and rBGH, which was used across the United States to boost milk production. The two have been banned by many other major dairy producers.
- Why is Monsanto so valuable to Bayer? -
Monsanto is by far the world's leading producer of genetically modified crop seeds, and in many of its seed lines it has a dominant market position.
According to Farm Journal, it had 35.5 percent of the market for corn in the United States in 2014. It had a 28 percent share for soybeans, behind DuPont.
The company owns around 1,700 patents. In 1991, it lost its patent on glyphosate herbicide, but retains a huge market share in part by having marketed its "Roundup-Ready" genetically modified seeds.
Monsanto also owns one of the leading data analytics firms for farmers, Climate Corp.
- What makes Monsanto so controversial? -
Many people and countries, especially in Europe, have not accepted the use of genetically modified organisms -- which they label "frankenfoods."
They say GMO seeds are dangerous to introduce to the farm and food system generally, and foods produced from GMO crops could turn out unsafe to eat.
In addition, Monsanto's strong market position, critics say, can leave farmers dependent on it because they cannot reproduce Monsanto crops with their own seeds due to the company's patents.
In addition, critics say the herbicides the company sells are dangerous to human health, and some have been banned in certain countries.
A merger with Bayer thus could give the combined company even more power in the market, with farmers already facing consolidation among suppliers.
In December, DuPont and Dow Chemical announce plans to merge, and in China National Chemical Corp. or ChemChina, made a $43 billion offer for Syngenta.
P.Martin--AMWN